To hear about similar clinical trials, please enter your email below
Trial Title:
Appraising Medical Trial Experiences of Ovarian Cancer Patients
NCT ID:
NCT05801796
Condition:
Ovarian Cancer
Conditions: Official terms:
Ovarian Neoplasms
Carcinoma, Ovarian Epithelial
Conditions: Keywords:
ovarian cancer
Study type:
Observational
Overall status:
Not yet recruiting
Study design:
Time perspective:
Prospective
Summary:
Historically, participation in clinical trials has been highly skewed towards specific
demographic groups. However, research identifying which trial attributes impact
participation, in either positive or negative ways, is limited. This study invites
participants to record a wide range of data on their clinical trial experience, with the
goal being to identify factors which persistently limit patients' ability to participate
in, or complete, a trial in which they were initially interested. Data will be analyzed
through a range of demographic lenses, in hopes of discovering patterns which might
improve the experience of future ovarian cancer patients.
Criteria for eligibility:
Study pop:
Ovarian cancer patients who are actively considering enrolling in a medical trial, but
have not yet completed enrollment and randomization.
Sampling method:
Probability Sample
Criteria:
Inclusion Criteria:
- Aged ≥ 18 years old and ability to provide written informed consent obtained prior
to participation in the study and any related procedures being performed
- Patient has been diagnosed with ovarian cancer
- Subjects willing and able to comply with the protocol for the duration of the study
including undergoing treatment and scheduled visits and examination.
Exclusion Criteria:
- Inability to perform regular electronic reporting
- Patient does not understand, sign, and return consent form
- Pregnant, breastfeeding or expecting to conceive within the projected duration of
the study
Gender:
Female
Gender based:
Yes
Minimum age:
18 Years
Maximum age:
N/A
Healthy volunteers:
No
Start date:
April 2024
Completion date:
April 2026
Lead sponsor:
Agency:
Power Life Sciences Inc.
Agency class:
Industry
Source:
Power Life Sciences Inc.
Record processing date:
ClinicalTrials.gov processed this data on November 12, 2024
Source: ClinicalTrials.gov page:
https://clinicaltrials.gov/ct2/show/NCT05801796
